Bibliographic information
GuidelineWHO recommendations on adolescent health: guidelines approved by the WHO guidelines review committee
Year of Publication2017
Issuing InstitutionWorld Health Organization
Recommendation
New
HIV-infected children and adults with severe seborrhoeic dermatitis and those patients with mild seborrhoeic dermatitis unresponsive to first-line therapy should be treated with a combination therapy of topical antifungals (e.g. ketoconazole 2%) and topical corticosteroids.
Recommended in favor
Strong
Certainty of evidence
Very low
Notes and Remarks
- 1)Mid- to high-potency topical corticosteroids can be used in combination with other medications (antifungals such as ketoconazole) but should be reserved for short-term therapy in severe seborrhoeic dermatitis or flare. Treatment of seborrhoeic dermatitis on sensitive areas such as the face should be limited to low-potency agents, whenever possible.